The U.S. needs 500 million doses of Covid-19 vaccine to fully inoculate everyone 16 and older, according to
Slavitt, who spoke Wednesday at the first news briefing of the administration’s Covid-19 task force, said that estimate assumes a two-dose regimen and reflects only the vaccines that are currently on the market.
“We are not counting on things that are not in existence today,” he said. Trial results for Johnson & Johnson’s one-dose vaccine are expected within days and could change the calculus dramatically, if authorized for emergency use.
The ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
